Share Awards to Executive Directors | 28-Oct-2024 | 12:57 | RNS |
EBT Share Purchase | 22-Oct-2024 | 11:00 | RNS |
EBT Share Purchase | 21-Oct-2024 | 07:00 | RNS |
EBT Share Purchase | 14-Oct-2024 | 11:07 | RNS |
Issue of Equity and TVR | 09-Oct-2024 | 07:00 | RNS |
Trading Update | 01-Oct-2024 | 07:00 | RNS |
Result of AGM | 27-Sep-2024 | 14:21 | RNS |
Director/PDMR Shareholding | 30-Aug-2024 | 15:07 | RNS |
Deferred Share Option Award to Executive Directors | 29-Aug-2024 | 07:00 | RNS |
Holding(s) in Company | 23-Aug-2024 | 13:18 | RNS |
Posting of the Annual Report and Notice of AGM | 16-Aug-2024 | 07:00 | RNS |
Block Listing Interim Review | 12-Aug-2024 | 13:30 | RNS |
Final Results | 15-Jul-2024 | 07:00 | RNS |
Notice of Results | 11-Jul-2024 | 09:30 | RNS |
Risk Profile Demonstrated for ECOVAXXIN MS | 08-May-2024 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 66.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 131.50p |
52 Week Low | 63.00p |
Volume | 71,091 |
Shares Issued | 67.76m |
Market Cap | £44.72m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
Latest | Previous | |
---|---|---|
Final | Final | |
Ex-Div | 23-Sep-21 | 26-Sep-19 |
Paid | 22-Oct-21 | 16-Oct-19 |
Amount | 1.00p | 7.04p |
Time | Volume / Share Price |
15:56 | 25,000 @ 64.00p |
16:20 | 4,664 @ 63.77p |
15:22 | 1,225 @ 63.77p |
15:19 | 11,058 @ 64.05p |
14:26 | 6,111 @ 65.30p |
CFO | Christopher Wilks |
CEO | David Hallas |
You are here: research